Jane Street Group, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $4.38 Million - $5.96 Million	63,500 New	63,500 $4.46 Million
Q1 2022 May 17, 2022	BUY	$74.28 - $92.69 $787,368 - $982,514	10,600 Added 6.4%	176,100 $13.6 Million
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $7.1 Million - $9.06 Million	99,000 Added 148.87%	165,500 $14.6 Million
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $844,901 - $965,811	-11,300 Reduced 14.52%	66,500 $5.14 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $3.5 Million - $3.93 Million	-46,400 Reduced 37.36%	77,800 $6.49 Million
Q1 2021 May 18, 2021	SELL	$74.73 - $90.69 $18.3 Million - $22.3 Million	-245,500 Reduced 66.41%	124,200 $9.38 Million
Q4 2020 Feb 17, 2021	BUY	$72.61 - $90.2 $16.1 Million - $20 Million	221,300 Added 149.12%	369,700 $32.4 Million
Q3 2020 Nov 17, 2020	SELL	$71.87 - $131.03 $862,440 - $1.57 Million	-12,000 Reduced 7.48%	148,400 $11.3 Million
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $12.1 Million - $18.9 Million	152,500 Added 1930.38%	160,400 $19.8 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $3.07 Million - $4.16 Million	-43,000 Reduced 84.48%	7,900 $668,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $2.69 Million - $3.62 Million	41,900 Added 465.56%	50,900 $4.3 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $47,180 - $59,577	-700 Reduced 7.22%	9,000 $607,000
Q2 2019 Aug 15, 2019	SELL	$80.35 - $93.9 $120,524 - $140,850	-1,500 Reduced 13.39%	9,700 $831,000
Q1 2019 May 16, 2019	SELL	$84.2 - $98.62 $412,580 - $483,238	-4,900 Reduced 30.43%	11,200 $995,000
Q4 2018 Feb 15, 2019	SELL	$80.14 - $106.07 $1.52 Million - $2.02 Million	-19,000 Reduced 54.13%	16,100 $1.37 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $2.12 Million - $2.39 Million	-22,600 Reduced 39.17%	35,100 $3.4 Million
Q2 2018 Aug 15, 2018	BUY	$76.01 - $99.03 $3.09 Million - $4.02 Million	40,600 Added 237.43%	57,700 $5.44 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $869,904 - $1.04 Million	11,200 Added 189.83%	17,100 $1.39 Million
Q4 2017 Feb 15, 2018	BUY	$80.76 - $95.13 $80,760 - $95,130	1,000 Added 20.41%	5,900 $526,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $394,940 - $465,255	4,900	4,900 $456,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.51 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.25 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$921 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$696 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account